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Abstract
Positron emission tomography with [18F] fluorodeoxyglucose (FDG-PET) plays a well-established role in assisting early
detection of frontotemporal lobar degeneration (FTLD). Here, we examined the impact of intensity normalization to
different reference areas on accuracy of FDG-PET to discriminate between patients with mild FTLD and healthy elderly
subjects. FDG-PET was conducted at two centers using different acquisition protocols: 41 FTLD patients and 42 controls
were studied at center 1, 11 FTLD patients and 13 controls were studied at center 2. All PET images were intensity
normalized to the cerebellum, primary sensorimotor cortex (SMC), cerebral global mean (CGM), and a reference cluster with
most preserved FDG uptake in the aforementioned patients group of center 1. Metabolic deficits in the patient group at
center 1 appeared 1.5, 3.6, and 4.6 times greater in spatial extent, when tracer uptake was normalized to the reference
cluster rather than to the cerebellum, SMC, and CGM, respectively. Logistic regression analyses based on normalized values
from FTLD-typical regions showed that at center 1, cerebellar, SMC, CGM, and cluster normalizations differentiated patients
from controls with accuracies of 86%, 76%, 75% and 90%, respectively. A similar order of effects was found at center 2.
Cluster normalization leads to a significant increase of statistical power in detecting early FTLD-associated metabolic
deficits. The established FTLD-specific cluster can be used to improve detection of FTLD on a single case basis at
independent centers – a decisive step towards early diagnosis and prediction of FTLD syndromes enabling specific therapies
in the future.
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Introduction
In brain imaging by means of positron emission tomography
(PET) and single-photon emission computed tomography
(SPECT), scaling of tracer uptake to a reference region is in most
cases essential for analyses of non-quantitative data. An ideal
reference region should not be affected by brain pathology and
should be easy to image/analyse. The choice of the appropriate
reference region is especially problematic in subjects with
neurodegenerative disorders who show early metabolic and
perfusion deficits [1–5].
Using statistical parametric mapping (SPM), we have recently
proposed a data-driven method for normalization of [18F]
fluorodeoxyglucose (FDG) uptake in cases with preclinical and
manifest Alzheimer’s disease (AD) dementia [6]. As compared
with traditional intensity normalization to an a priori defined
reference region, the reference cluster (RC) is defined by a contrast
showing areas with increased activity in patients relative to
controls after global mean normalization. This RC approach
proved to detect AD-related hypometabolism in a more sensitive
manner than traditional ROI-based normalizations [6]. Originally
developed on clinical image data, the method was soon validated
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in simulation studies and extended to perfusion studies in
Parkinson’s disease (PD), another common neurodegenerative
disorder [7–9].
To be applicable in clinical settings, any diagnostic test must be
robust to variability in clinical presentation/assessments and
methodological factors. To this end, we performed a bi-central
study with a cross-validation design in frontotemporal lobar
degeneration (FTLD). As compared to AD and PD, FTLD is
characterized by a substantially higher heterogeneity in respect to
histopathological, clinical, and imaging presentation [10–12].
FDG-PET plays a well-established role in assisting early detection
and differentiation of this severe neurodegenerative disorder [13–
25], after AD the second most common cause of presenile
dementia [26]. Furthermore, as compared to previous single-
center applications of the RC normalization in AD and PD
[6,27,28], here we assess performance of the method in cross-
center settings. I.e., a RC obtained at one center is applied for data
normalization from another center. Results of this data-driven
approach are then compared with normalization to common
reference regions.
In this work, we examine the impact of intensity normalization
to cerebellum (CBL), primary sensorimotor cortex (SMC), cerebral
global mean (CGM) and to RC on the accuracy of FDG-PET to
detect FTLD-specific metabolic deficits and to discriminate
between patients with mild FTLD and healthy subjects.
Methods
Subjects
Patients were retrospectively identified from a database of
subjects from the memory clinic of the Department of Psychiatry
at the Technische Universita¨t Mu¨nchen (hereafter referred to as
center 1) and from the Clinic of Cognitive Neurology at the
University of Leipzig (thereafter referred to as center 2). In both
centers all patients were diagnosed according to Neary diagnostic
criteria of FTLD [29]. The diagnosis was based on the information
from a thorough neurological and psychiatric examination,
informant interview, routine blood sampling, MRI, and FDG-
PET imaging. Only patients with a Mini-Mental-State Examina-
tion (MMSE) score .21 were included. For two patients at center
2 MMSE was not available. In this case, a clinical dementia rating
(CDR) score of less or equal to 1 was applied as an inclusion
criterion [30]. Thus, we aimed to include patients with a mild
disease severity only. Exclusion criteria were evidence for lesions
due to stroke, traumatic head injury, brain tumor or inflammatory
diseases on structural MRI. Using these criteria, 41 patients were
included at center 1 and 11 at center 2.
The control group at center 1 (n = 42) consisted of elderly
individuals without relevant psychiatric or neurological symptoms;
subjects were only included if they did not report subjective
memory complaints and if they did not show evidence for
cognitive impairment.
The control group at center 2 (n = 13) included subjects who
visited the Clinic of Cognitive Neurology at the University of
Leipzig with subjective cognitive complaints, which were not
objectively confirmed by a comprehensive neuropsychological and
clinical evaluation.
This study was carried out in accordance with the latest version
of the Declaration of Helsinki after the consent procedures had
been approved by the local ethics committees of the University of
Leipzig and of the medical faculty at the Technische Universita¨t
Mu¨nchen. Written informed consent was obtained from all control
subjects, all patients at center 2 and from most patients at center 1.
Some patients at center 1 only gave oral informed consent for
participation in the study as PET examination in patients was part
of routine diagnostic work-up. Such a study-specific written
consent was not obtained because all the procedures are included
in a diagnostic work-up for suspected neurodegenerative disorder.
Irrespective of this, all patients or their proxy gave a written
consent for the PET examination. Additionally the process was
documented by standard hospital documentation including an
indication for the diagnostic work-up (due to suspected neurode-
generative disorder). The standard written (in German) consent
includes the following items: 1) Aim of the study/PET examina-
tion, 2) Contraindications to the PET examination, 3) Procedure
of the PET examination, 4) Expences and allowance, 5) Data
protection, 6) Personal benefits, 7) Risks, complications and side-
effects, 8) Insurance, 9) Responsible persons and consent to
Table 1. Subject group characteristics.
Center 1 Center 2
Controls FTLD Controls FTLD
Number 42 41 13 11
Male/Female 18/23 30/11 7/6 7/4
Age (years) 61.7610.3 64.069.4 53.965.8 61.665.5
CDR (score) - - 0.260.2 0.760.2
MMSE (score) - 25.561.8 - 26.062.1
Mean 6 standard deviation. CDR Clinical Dementia Rating Scale, FTLD
frontotemporal lobar degeneration, MMSE Mini Mental State Examination.
doi:10.1371/journal.pone.0055415.t001
Figure 1. Region showing an increased glucose metabolism in frontotemporal lobar degeneration compared to control subjects in
center 1 after normalization to cerebral global mean. A significance threshold of p,0.000001 family-wise error corrected at voxel level was
applied. This region was used as reference cluster for the subsequent intensity normalization.
doi:10.1371/journal.pone.0055415.g001
Reference Cluster Normalization in FTLD
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participate. As patients were studied with PET as a part of
diagnostic work-up, items 4,6,8 and were not applicable. We
confirm that all potential participants who declined to participate
or otherwise did not participate were eligible for treatment and
were not disadvantaged in any other way by not participating in
the study. Demographic characteristics of participants are
presented in Table 1.
Data acquisition
Scans were acquired under standard resting conditions with
eyes closed at center 1 and in dimmed ambient light with eyes
open at center 2, using a Siemens ECAT EXACT HR+ PET
scanner (CTI, Knoxville, TN, USA).
At center 1, the acquisitions were performed in 3D mode with a
total axial field of view of 15.52 cm and no interplane dead space.
A sequence of three frames with a duration of 10, 5 and 5 min was
acquired for each subject starting 30 min post injection. At center
2, data were acquired in 2D mode. A sequence of three frames
(10 min each) was acquired for each subject starting 30 min post
injection. Sixty-three slices were collected at both centers with an
axial resolution of 5 mm full width at half maximum (FWHM) and
in-plane resolution of 4.6 mm. After correction for attenuation,
scatter, decay and scanner-specific dead time at both centers,
images were reconstructed by filtered back-projection using a
Hann-filter (center 1: cutoff frequency 0.5 cycles/projection
element; center 2: 4.9 mm FWHM). Slices obtained had a
resolution of 1286128 voxels with an edge length of 2.425 mm
at center 1 and 2.45 mm at center 2.
Data pre-processing
Statistical Parametric Mapping software (SPM8). http://www.
fil.ion.ucl.ac.uk/spm/) implemented in Matlab 7.11 (MathWorks
Inc., Sherborn, MA) was used for image processing and statistical
analyses. After spatial realignment a mean image of the three
frames was calculated for each subject. The image sets were
spatially normalized using an in-house tracer-, scanner- and age-
specific brain PET template (in MNI space) based on all available
images, separately in each center. Normalized images with a voxel
size of 26262 mm were than smoothed with a Gaussian kernel of
12 mm FWHM. Regional value extraction for subsequent
intensity normalization to CBL and to SMC was performed the
automatic anatomical labeling atlas (AAL, [31]). All AAL regions
belonging to cerebellar hemispheres and SMC were used as a
single volume-of-interest for intensity normalization to CBL and
SMC, respectively. The value of CGM was calculated using the
global calculation function with default settings, as implemented in
SPM [32,33].
Voxel-based analyses
To obtain a representative FTLD-specific RC, we used data
from center 1, as substantially more data sets were available. By
analogy with the original work [6], we computed a contrast
representing relative increases in the whole patient group (n= 41)
compared to the control sample (n = 42), using normalization to
CGM. As we had no experience with such a contrast in FTLD, no
a priori probability threshold was chosen. Instead, we started with
a threshold of p,0.05 FWE-corrected at voxel level and increased
it until most of the resultant cluster volume could be clearly
assigned to one specific anatomical region. Under the threshold of
p,.000001 FWE-corrected at voxel level we obtained a single
cluster that projected to the cerebellum. Of note, its volume was
still sufficiently large, covering 4321 voxels. The cluster encom-
passed the medial and anterior parts of the cerebellar hemispheres
as well as the cerebellar vermis (Figure 1). A small part of the
cluster volume included the lower parts of the occipital cortex.
Further, we specified conventional contrasts representing
relative decreases in the patient group (n= 41) relative to the
control sample (n = 42). To evaluate the impact of normalization
onto detection of FTLD specific hypometabolism, image intensity
in these analyses was normalized to CGM, CBL, SMC, and RC as
obtained above. To examine performance of normalization to RC
in an independent sample, the same analyses were performed for
data from center 2. Age and gender were included as nuisance
variables in all analyses. A statistical threshold of p,.001
uncorrected at voxel level and p,0.05 FWE-corrected at cluster
level was applied in all analyses. Extent threshold was set at k.100
contiguous voxels. Detected glucose hypometabolism was com-
pared between the normalization procedures in terms of cluster
size and maximum t-value. Anatomical labeling of significant
Table 2. Hypometabolism in patients with frontotemporal
degeneration after intensity normalization to different
reference regions.
Center 1 Center 2
Cluster
extent
Peak
t-value
Cluster
extent Peak t-value
CGM 36806 8.7 n.s. n.s.
SMC 46215 8.9 1652 5.0
Cerebellum 108383 9.5 1281 4.3
RC 167801 10.9 7216 5.1
The cluster extent is represented by the sum of all clusters (in voxels) which
exceeded an threshold p,0.001 (uncorrected) at voxel level and p,0.05
(family-wise error corrected) at cluster level. CGM cerebral global mean, SMC
primary sensorimotor cortex, RC reference cluster.
n.s. not significant.
doi:10.1371/journal.pone.0055415.t002
Figure 2. Regions showing a significant decrease in glucose
metabolism in frontotemporal lobar degeneration compared
to control subjects in center 1 (left) and 2 (right) after intensity
normalization to different reference regions, in particular
primary sensorimotor cortex (SMC), cerebral global mean
(CGM), cerebellum (CBL), and reference cluster (RC).
doi:10.1371/journal.pone.0055415.g002
Reference Cluster Normalization in FTLD
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clusters was performed using AAL [31] implemented in the WFU
PickAtlas tool [34,35].
Logistic regression analyses
Accuracy for discrimination between FTLD patients and
control subjects was calculated using logistic regressions with
split-half cross-validation separately for each center and normal-
ization. Thereby, the diagnostic labels were used as the dependent
variable. As independent variable we used individual mean FDG-
uptake values extracted after each type of intensity normalization.
All mean values were extracted from the hypometabolic pattern
detected after CBL normalization (Figure 2) as a kind of gold
standard. Indeed, this reference region has been widely applied in
FDG-PET imaging of FTLD and has been shown to be the most
sensitive approach for diagnostic purposes [2]. Additionally, we
extracted mean values from an overlap of hypometabolic patterns
detected using all reference regions at center 1. This pattern
included bilateral frontal and anterior temporal regions. To obtain
accuracy distributions, the split-half cross-validation procedure
was repeated 5000 times by randomly assigning patients and
control subjects to training and testing datasets and calculating
prediction accuracies for the data not used for training. Accuracy,
sensitivity and specificity distributions obtained for FTLD patients
and control subjects after normalization to each reference region
were compared to each other using t-tests for independent samples
and applying a significance threshold of p,.05 (Bonferroni
corrected for multiple comparisons). Logistic regressions and t-
tests comparing the obtained accuracies were implemented using
functions provided by Matlab.
Demographic characteristics
Group comparisons for age were performed by conducting
Student’s t-tests with a two-sided significance threshold of p,0.05
implemented in Matlab 7.11. Group differences regarding gender
were evaluated using a chi-square test for independence using the
commercial software package SPSS 17.0 (http://www.spss.com/
statistics/).
Results
Demographic results
The chi-square test for independence did not reveal any
statistical differences in gender between the groups at center 2
[x2(1) = .24; p = 0.628]. Gender distribution between FTLD
patients and control subjects differed significantly at center 1
[x2(21) = 7.82; p = 0.005]. There was a minor but significant
difference in age between control subjects and FTLD patients at
center 2 [t(22) =23.19; p = 0.004], which was taken generally into
account in the following analyses by including age as a covariate.
No significant difference in age was observed at center 1
[t(81) = 0.98; p= 0.328].
Voxel-based analyses
The comparison of FTLD patients and control subjects at
center 1 revealed a significantly lower relative FDG uptake in
bilateral frontal, anterior temporal, cingulate cortices, caudate
nucleus and thalamus for CGM and SMC (Figure 2 and Table 2).
Decreased relative FDG-uptake was more pronounced, both in
respect to extent and height, after intensity normalization to CBL
and RC, sparring only occipital, cerebellar and vermis regions
after normalization to CBL while only the vermis after normal-
ization to RC. For data from center 2, effects were generally
smaller. Left-hemispheric lower relative tracer uptake was detected
in FTLD patients in inferior and middle frontal gyrus, pars
triangularis, anterior superior, middle, inferior temporal gyrus and
precentral gyrus after normalization to CBL. Normalization to RC
additionally revealed lower relative FDG uptake in left fusiform
gyrus, supramarginal gyrus, frontal inferior operculum, angular
gyrus, inferior orbital gyrus, insula, rolandic operculum, para-
hippocampal and inferior parietal regions. Normalization to SMC
revealed lower relative tracer uptake only in left middle and
superior frontal gyrus, parts of the precentral gyrus, pars
triangularis and operculum. No significant cluster was detected
in patients from center 2 after normalization to CGM.
For data from center 1, the opposite contrast investigating
increases in glucose uptake in patients resulted in appearance of
significantly higher FDG uptake in CBL, primary sensorimotor,
occipital and parietal regions of patients after normalization to
SMC and CGM (Figure 3). After normalization to CBL higher
FDG uptake was only detected in vermis and parts of CBL. No
significant clusters were observed after normalization to RC. For
data from center 2, no significant clusters were observed in FTLD
patients after any type of normalization.
Logistic regression
In analyses with mean uptake values extracted from the
hypometabolic pattern detected using CBL as a reference region
normalization to RC provided significantly higher (p,0.001)
mean accuracies for discrimination between FTLD patients and
control subjects in both cohorts (center 1: 90.4%; center 2: 97.3%)
as compared to all other reference regions (Figure 4). Normali-
zation to CBL performed second best in both centers (center 1:
86.2%; center 2: 91.9%). CGM (90.1%) was superior to SMC
(86.9%) at center 2 whilst the opposite was the case at center 1
(CGM: 75%; SMC: 76.1%). The differences between all
normalization procedures were highly significant (p,0.001).
When comparing sensitivities and specificities between different
normalization procedures, again all comparisons with the excep-
tion of the comparison of sensitivities for CGM and SMC
Figure 3. Regions showing an increase in glucose metabolism
in frontotemporal lobar degeneration compared to control
subjects in center 1 after intensity normalization to different
reference regions, in particular primary sensorimotor cortex
(SMC), cerebral global mean (CGM), cerebellum (CBL), and
reference cluster (RC).
doi:10.1371/journal.pone.0055415.g003
Reference Cluster Normalization in FTLD
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normalizations at center 1 (p = 1.0) were highly significant
(p,.001) showing the same order as the total accuracies. At both
centers, sensitivities were significantly lower (p,0.001) than
specificities after normalization to all reference regions with the
exception of normalization to RC at center 1 (p = 1.0).
Logistic regressions calculated in center 1 and center 2 based on
the overlap of all clusters detected in the corresponding center
revealed highly similar accuracy distributions (center 1: RC:
88.5%; CBL: 86.8%; CGM: 82.4%; SMC: 78.4%; center 2: RC:
88.7%; CBL: 78.3%; CGM: 81.8%; SMC: 79.6%) with the only
difference that CGM was now superior to SMC at center 2
(Figure 4). All differences were again highly significant (p,0.001).
Similarly, the obtained sensitivities and specificities differed
significantly (p,.001) between all normalization procedures
except for the comparison of sensitivities obtained after CGM
and SMC normalization (p = 1.0) and of specificities for the
comparison of CBL and SMC normalization (p = 1.0), both at
center 2. At both centers, all sensitivities were significantly lower
than the specificities (p,.001).
Discussion
In the present study, we compared performance of data-driven
RC normalization [6] with that of normalization to CGM, CBL
and SMC in mild FTLD. The major finding is that RC
normalization allowed for a more accurate detection of early
FTLD related metabolic deficits than normalization to any
common reference region. Furthermore, this superior perfor-
mance held its standing after cross-validation, i.e. when a
representative RC cluster was applied to image data from another
center that were acquired with a different protocol.
The proposed method of intensity normalization is in essence
based on the assumption that CGM metabolism is significantly
decreased in patients with neurodegenerative disorders. Although,
to the best of our knowledge, this has not been explicitly reported
in FTLD, this is rather expected, taking into account the presence
of rather extensive regional metabolic deficits already at mild
disease stages [20,36]. When comparing patients vs. healthy
subjects, intensity normalization to CGM may lead to two
unwanted effects in the patient group: underestimation of true
regional hypometabolism or -perfusion and detection of apparent
(but false) regional hypermetabolism or -perfusion due solely to
overcorrection of global variation [37,38]. Here we show that both
effects, in an extensive manner, indeed take place in FTLD, even
at a mild disease stage. Moreover, under the same probability
threshold, the extent of apparent hypermetabolism is substantially
larger than that of true hypometabolism (data not shown). This
observation suggests that so-called global normalization alone
should not be applied in the comparison of FTLD patients vs.
control subjects, even at mild disease stages. However, this
procedure may be beneficial in detecting regions that are relatively
preserved in a given neurodegenerative disease [6,9,27]. Here we
demonstrate that intensity scaling to such regions increases
statistical power in detecting FTLD-related regional deficits.
Moreover, this gain appears substantial enough to significantly
increase accuracy of discrimination between patients with mild
FTLD and healthy elderly subjects.
While CGM and CBL have been most widely used for scaling of
tracer uptake in FTLD (e.g., CGM: [2,19,39,40]; cerebellum:
Figure 4. Accuracies, sensitivities and specificities are displayed for each type of intensity normalization. Accuracies, sensitivities and
specificities were obtained using mean uptake values extracted from the cerebellar cluster (center 1 (a), center 2 (b)) and from the overlap of all
clusters detected at center 1 (center 1 (c), center 2 (d)) for differentiation between frontotemporal lobar degeneration patients and control subjects
using logistic regressions. Mean values and standard deviations (error bars) obtained after 5000 permutations using split-half cross-validation are
displayed. SMC primary sensorimotor cortex, CBL cerebellum, CGM cerebral global mean, RC reference cluster.
doi:10.1371/journal.pone.0055415.g004
Reference Cluster Normalization in FTLD
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[2,17,41,42], the SMC was included, because it was shown to be a
valuable reference area in AD [1]. As expected, CBL was superior
to CGM, but it was also superior to SMC. This finding is in line
with a quantitative FDG-PET study on FTLD [4] as well as with
evidence from histopathological literature [43,44]. The fact that
our RC was also localized within the CBL further supports the
view that CBL is a reference area of choice in FTLD. Our data
indicate, however, that parts of the cerebellar cortex are probably
also hypometabolic. Thus, the RC identifies the cerebellar
subregion that is most conserved, and therefore provides the least
biased normalization. This interpretation also explains why the
RC performs better than employing an a priori CBL region in its
entirety. In particular, we found that FDG uptake in the anterior-
medial parts of the cerebellar hemispheres, as well as in the vermis,
was most preserved in our patients with mild FTLD. Such a
pattern might be a result of cerebellar diaschisis with a specific
degeneration of cerebropontine-cerebellar pathways [45]. It
should be noted, however, that FTLD is a heterogeneous group
of diseases, so there might be subtype-specific patterns of preserved
glucose metabolism.
In a second step, we asked if the derived RC is representative
enough to improve detection of hypometabolism in an indepen-
dent cohort from another center. Indeed, RC normalization was
still significantly superior to other commonly used reference
regions. Of note, the image data from the independent cohort
were acquired using different acquisition protocols. Furthermore,
as compared to control subjects at center 1, the control group at
center 2 consisted of individuals with subjective cognitive
complaints. Indeed, the latter situation is even closer to routine
clinical practice, where a differentiation between such subjects and
patients with a suspected neurodegenerative disorder might be
really challenging. Nonetheless, RC normalization significantly
improved discrimination between these control subjects and
patients with mild FTLD. These findings suggest that the derived
FTLD-specific RC is rather robust to between-center variability in
data acquisition and clinical assessments. Thus, the cluster can be
used in independent centers, both on a group and single subject
basis.
This study has some limitations. Firstly, the sample size from the
center 2 was relatively small. However, given the observation of a
similar superiority of the RC approach in a second substantially
bigger sample we feel confident that the results reflect a true
difference between normalization procedures. However, the
substantially smaller sample size in center 2 might explain the
lower degree of hypometabolism detected in this FTLD cohort.
Secondly, according to standards of clinical work, our PET data
were acquired without arterial or venous blood sampling. As we
analyzed only relative FDG-uptake, we cannot exclude the
presence of true hypermetabolism in our patients with FTLD.
To the best of our knowledge, however, there have been no reports
describing increases in resting state regional metabolism in subjects
with FTLD. Nonetheless, caution is needed when applying the RC
approach in psychiatric or neurological disorders where hyper-
metabolism or hyperperfusion might be part of the disease process.
Furthermore, accuracy values provided by RC normalization at
center 1 might be overoptimistic, as the RC was obtained on the
basis of the same image data. Yet, application of the same cluster
to an independent cohort of subjects from center 2 resulted in a
similar accuracy increase. Of note, this was also the case when
normalizing image data from center 1 to a RC obtained at center
2 (data not shown). Although there was a substantial overlap
between two clusters, we chose the one from center 1 to be applied
in major analyses, as it is based on substantially more cases.
Furthermore, we did not apply correction for partial volume
effects. However, in our previous work on the same study sample
from center 2 we have shown that partial volume effect correction
has only little effect on the comparison of different normalization
procedures [2]. Finally, and perhaps most importantly, the
methodology presented in this paper is not generalized to the
clinical practice in which an expert in nuclear medicine encounters
with a large spectrum of conditions/disorders on a single-subject
basis. This essential issue should be addressed in future studies with
a different design. While we fully admit the indispensable value of
visual scan reading in clinical settings, an increasing role of
automated image-based classification procedures that can be
applied to analyses of large-scale image databases in a user-
independent manner should be recognized and noted [46,47].
Logistic regression analyses such as those applied in the present
study are a common step in such classification algorithms.
However, it is important to note that the purpose of our study
was not to develop or to establish a classification algorithm but
rather to the examine how classification accuracy of automated
classification procedures on the same data is influenced by the
choice of reference region for intensity normalization.
In summary, we found that data-driven RC normalization
improves detection of glucose hypometabolism in mild FTLD.
Such an improvement appears substantial enough to increase
accuracy of discrimination between FTLD patients and healthy
subjects, also in an independent cohort. The established FTLD-
specific cluster can be used for intensity normalization at
independent imaging centers. The cluster as binary image is
available for free download at http://www.unil.ch/webdav/site/
lren/shared/Juergen/wRefClus_Munich_41Pat42Kon_FWE0.
000001.nii.
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